Literature DB >> 899740

Clofibrate-induced myopathy in the rat.

H Teräväinen, A Larsen, M Hillbom.   

Abstract

Rats were given daily injections of 0.2 or 0.5 g/kg chlorophenoxyisobutyrate (clofibrate) for 9 to 46 days. Lower leg muscles were studied with light and electron microscopy. Daily treatment with 0.5 g/kg of the drug for 26--46 days caused myopathic changes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 899740     DOI: 10.1007/bf00703319

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Clofibrate, nephrotic syndrome, and histological changes in muscle.

Authors:  M Denizot; J Fabre; D Pometta; E Wildi
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

2.  Procedure for the histochemical demonstration of actomyosin ATPase.

Authors:  L Guth; F J Samaha
Journal:  Exp Neurol       Date:  1970-08       Impact factor: 5.330

3.  Muscular syndrome after clofibrate.

Authors:  N Katsilambros; J Braaten; B D Ferguson; R F Bradley
Journal:  N Engl J Med       Date:  1972-05-18       Impact factor: 91.245

4.  Acute muscular syndrome associated with administration of clofibrate.

Authors:  T Langer; R I Levy
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

5.  Clofibrate-induced muscle damage in patients with chronic renal failure.

Authors:  A M Pierides; F Alvarez-Ude; D N Kerr
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

6.  Mode of inhibition of mitochondrial energy transduction by chlorophenoxyisobutyrate.

Authors:  S R Panini; C K Kurup
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

7.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

8.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02

9.  Staining of tissue sections for electron microscopy with heavy metals.

Authors:  M L WATSON
Journal:  J Biophys Biochem Cytol       Date:  1958-07-25

10.  Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation.

Authors:  D D SABATINI; K BENSCH; R J BARRNETT
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  10 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 2.  Bezafibrate induced rhabdomyolysis.

Authors:  E Kanterewicz; R Sanmartí; J Riba; I Trias; J Autonell; J Brugués
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Mitochondrial myopathy--a result of clofibrate/etofibrate treatment? Case report.

Authors:  A Bardosi; P Scheidt; H H Goebel
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Clofibrate-induced myotonia in the rat.

Authors:  A Eberstein; J Goodgold; R Johnston
Journal:  Experientia       Date:  1978-12-15

5.  Effects of clofibric acid on the activity and activity state of the hepatic branched-chain 2-oxo acid dehydrogenase complex.

Authors:  Y Zhao; J Jaskiewicz; R A Harris
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 6.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

7.  Ultrastructural alterations in skeletal muscle of pigs with acute monensin myotoxicosis.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

8.  Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid.

Authors:  W M Pardridge; D Casanello-Ertl; L Duducgian-Vartavarian
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

Authors:  S Levak-Frank; H Radner; A Walsh; R Stollberger; G Knipping; G Hoefler; W Sattler; P H Weinstock; J L Breslow; R Zechner
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.